Search Results
Profile
NHGRI researchers recently published a study using virtual reality simulations to investigate how clinicians might use a type of genomic risk information called polygenic risk scores in medical care.
… with a specific health condition such diabetes and cancer. The study was conducted by the research group headed … genomic risks for a variety of health conditions, such as breast cancer, obesity and heart diseases. Although such risk …
News Release
A study published NIH researchers revealed that about half of individuals who said they don’t want to receive secondary genomic findings changed their mind after their healthcare provider gave them more detailed information.
… variants that are associated with a heightened risk for breast cancer. Based on the American College of Medical Genetics and … BRCA2 , both of which are linked to an increased risk of breast and ovarian cancer. All 59 genes are associated with …
File
… the best models, lessons from diverse complex diseases: Breast Cancer …
FAQ
Questions and answers from the September 26, 2022, Multi-Omics for Health and Disease Consortium Pre-Application Webinar.
… both tumor and normal tissues from participants with cancer are strongly encouraged and will be prioritized for … Biosamples For the cancer DSS, can we propose just plasma collection and no … Collection of tumor samples from participants with cancer is encouraged but it is not a strict requirement. See …
Careers and Training
NHGRI provides funding to support the development and implementation of modules aimed at providing healthcare professionals with genomic medicine training.
… of ACT sheets for select high risk PRS diseases (Breast Cancer, Heart Disease, Diabetes) that can be adapted to … variants we currently use clinically for diseases such as breast cancer, colon cancer, and coronary artery disease. …
Policy Issues
Payers such as insurance companies and Medicare need systematic ways of evaluating genetic tests for reimbursement.
… tests to predict, prevent and treat disease. Tests for breast cancer and for hereditary forms of colorectal cancer can assess disease risk and guide screening and …
For Patients and Families
​Genetic research is creating new ways for people to take action and prevent disease and new ways to treat disease through personalized medicine.​ ​
… long time that common diseases like heart disease, asthma, cancer, and diabetes can run in families. Rare diseases like … called Herceptin will be an effective treatment in breast cancer. This test looks "estrogen receptors" in tumors. …
For Patients and Families
​Pharmacogenomics combines the science of how drugs work, called pharmacology, with the science of the human genome, called genomics.​
… to better ways of using drugs to manage heart disease, cancer, asthma, depression and many other common diseases. … to have a bad reaction to the drug. Another example is the breast cancer drug trastuzumab (Herceptin). This therapy works only … not work well in people with a certain genetic variant. Cancer is another very active area of pharmacogenomic …
News Release
As researchers uncover millions of DNA differences in genes, doctors struggle to know which of these inherited differences, called variants, really matter.
… of Child Health and Human Development and the National Cancer Institute, all part of NIH. "ClinGen is both setting … evidence that mutations dramatically raise the risk for breast and ovarian cancer. Yet for many genes and variants, the evidence is less …
Genetic Disorders
Poland anomaly is an underdevelopment or absence of the chest muscle on one side of the body and webbing of the fingers of the hand on the same side.
… or missing. And in females, this may extend to the breast and underlying tissues. Abnormally short, webbed … 13. For females, surgery may have to be postponed until breast development is complete. Reconstructive surgery can be … tattooing. This treatment is intended to give the breast the appearance of a nipple and areola. …